Wulun Yang

Title: Wulun Yang: Innovator in Medicinal Chemistry

Introduction

Wulun Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the human body.

Latest Patents

Wulun Yang holds a patent for "Pyridine derivatives as agonists of the CB2 receptor." This invention relates to a compound of formula (I), wherein R, R, R, and R are defined as in the description and claims. The compounds developed by Yang are preferential agonists of the Cannabinoid Receptor 2, making them useful as medicaments. They may be employed in the treatment of chronic pain, atherosclerosis, ischemic/reperfusion injury, and other related diseases. A representative compound from this invention is 6-cyclopropylmethoxy-5-(tetrahydro-pyridine-2-carboxylic acid [1-methyl-1-(5-methyl-(1,2,4)oxadiazol-3-yl)-ethyl)-amide.

Career Highlights

Wulun Yang is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work focuses on the development of innovative therapeutic solutions that address various medical conditions.

Collaborations

Yang has collaborated with notable colleagues, including Caterina Bissantz and Uwe Grether. These collaborations have contributed to the advancement of research and development in the field of medicinal chemistry.

Conclusion

Wulun Yang's contributions to the field of medicinal chemistry, particularly through his patented innovations, highlight his role as a key inventor in the industry. His work continues to pave the way for new therapeutic options in medicine.